Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloid-derived suppressor cells and their role in pancreatic cancer.

Cancer gene therapy - 1 Mar 2017

Pergamo M, Miller G

Abstract excerpt

Pancreatic cancer is a devastating disease and ranks as the third most common cause of cancer-related death. Like many cancers, there has been increased interest in the role of the immune system in the progression and development of pancreatic cancer. In particular, immunosuppression within the tumor microenvironment (TME) is thought to impair the host's antitumor response. In this article, we review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Cell Communication
Share to Immunologic Surveillance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunomodulation

Share to Molecular Targeted Therapy

Share to Myeloid-Derived Suppressor Cells

Share to Pancreatic Neoplasms

Share to Tumor Microenvironment

Source

Identifiers

PMID: 27910857
DOI: 10.1038/cgt.2016.65

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloid-derived suppressor cells and their role in pancreatic cancer.PMID 27910857Read ↗

Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic CancerSemantic proximity Read ↗

Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell TherapiesSemantic proximity Read ↗

Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer.Semantic proximity Read ↗

Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.Semantic proximity Read ↗

S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro studySemantic proximity Read ↗

Killing the "BAD": Challenges for immunotherapy in pancreatic cancer.Semantic proximity Read ↗

The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implicationsSemantic proximity Read ↗

CD4+ T Lymphocyte Ablation Prevents Pancreatic Carcinogenesis in MiceSemantic proximity Read ↗

The role of inflammatory cells in fostering pancreatic cancer cell growth and invasionSemantic proximity Read ↗

Targeting tumor tolerance: A new hope for pancreatic cancer therapy?Semantic proximity Read ↗

Comparative phenotypes of peripheral blood and spleen cells from cancer patients.Semantic proximity Read ↗

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.